6 February 2026 in Turkish Journal of Thoracic and Cardiovascular Surgery
Patient-prosthesis mismatch after aortic valve replacement: Effects on left ventricular structure - Turkish Journal of Thoracic and Cardiovascular Surgery
23 September 2023 in SDÜ Tıp Fakültesi Dergisi
Aim of the study Acute coronary syndrome (ACS) is a disease associated with high mortality and morbidity. It is essential to identify high-risk patients during hospitalization and to implement early revascularization strategies if necessary. There is a clear need for a simple, effective and cost-effective index for rapid identification of these patients in clinical practice. The aim of this study was to investigate the clinical significance of the systemic immune inflammation index (SII) in non-ST-segment elevation myocardial infarction (NSTEMI), a subgroup of ACS, and to evaluate its association with mortality. Materials and methods Patients who underwent coronary angiography at the Coronary Angiography Unit of Aydın Adnan Menderes University Faculty of Medicine Research and Training Hospital between January and December 2022 were retrospectively reviewed. Individuals with a diagnosis of NSTEMI were included as group I, and individuals with normal coronary arteries during coronary angiography were included as group II (control group). Clinical variables and calculated SII values of the groups were recorded. The role of SII in predicting all-cause mortality and its effect on expected survival were evaluated. Results The median value of the SII index was significantly higher in the NSTEMI group (group I) than in the control group (group II) (p<0.001). The mean neutrophil and SII index values of the mortality group were significantly higher than those of the survival group (p=0.002 and p=0.019, respectively). Multivariate logistic regression showed that the presence of NSTEMI (odds ratio [OR]: 9.891; 95% CI: 2.096-46.671, p609.98 and 79.3% for group I patients with SII <609.98, but the difference was not statistically significant (p=0.426). Conclusion Although the SII index has a role in predicting all-cause mortality in patients with NSTEMI, it is not useful in predicting survival. Amaç: AKS mortalitesi ve morbiditesi yüksek bir sendromdur. Yüksek riskli hastaların hastane yatışı esnasında belirlenmesi ve gerekli durumlarda erken revaskülarizasyon stratejilerinin uygulanması hastalarda hayati önem arz etmektedir. Klinik pratikte bu hastaların hızlıca belirlenmesine yönelik basit, etkili, maliyeti ucuz bir indeks ihtiyacı olduğu aşikardır. Tüm bu nedenlerden dolayı bu çalışmada tarafımızca SII’nın, AKS alt grubu olan NSTEMI geçiren hastalarda mortaliteyi ön görmedeki yerinin araştırılması amaçlanmıştır. Gereç ve Yöntem: 01.01.2022-31.12.2022 tarihleri arasından Aydın Adnan Menderes Üniversitesi Tıp Fakültesi Uygulama ve Araştırma Hastanesi koroner anjiyografi ünitesinde koroner anjiyografi işlemi uygulanan hastalar geçmişe dönük olarak tarandı. St segment yükselmesiz miyokart enfarktüsü geçiren hastalarda ve normal koroner arterler saptanan hastalarda SII [(nötrofil x platelet) / lenfosit] hesaplandı. Bu indeks ile tüm nedenlere bağlı mortalite gelişimi arasında ilişki olup olmadığı araştırıldı. Bulgular: Grup 1 olarak değerlendirilen NSTEMI grubu SII indeks ortancası Grup II’ye göre anlamlı düzeyde yüksek bulundu (p<0.001). Mortalite gözlenen gruba ait nötrofil ve SII indeksi değerleri ortalaması, sağkalım grubuna göre istatistiksel olarak anlamlı derecede yüksek bulundu (sırasıyla p=0.002 ve p=0.019). Çok yönlü lojistik regresyon sonucunda, NSTEMI varlığı yaş (odds ratio [OR]: 9.891; 95% CI: 2.096-46.671, p<0.001) ve SII indeksinin (odds ratio [OR]: 1.001; 95% CI: 1.000-1001, p=0.039) tüm nedenlere bağlı mortaliteyi bağımsız olarak öngördüğü saptandı. NSTEMI grubunda SII indeksi 609.98 değerinden yüksek olguların sağkalım beklentisi 18 ay için %68.1, SII indeksi 609.98 değerinden düşük olgular için ise %79.3 olarak hesaplandı ancak fark istatistiksel olarak anlamlı bulunmadı (p=0.426). Sonuç: SII, NSTEMI hasta grubunda mortaliteyi ön görmede faydalı bir indeks değildir.
28 March 2023 in Turkish Journal of Health Science and Life
Background: Post-pericardiotomy syndrome (PPS) is a common complication after cardiovascular surgery. Post-operative hospitalizations are prolonged due to PPS and mortality is increased due to pericardial effusion leading to cardiac tamponade. Studies have shown that inflammation plays a role in etiology. Objectives: The systemic immune-inflammation index (SII) is a new non-invasive marker that has been shown to be effective in predicting inflammatory diseases. In our study, we aimed to investigate the association between the development of PPS and SII in patients undergoing open-heart surgery Methods: Patients who underwent elective open-heart surgery at our institution between 2017 and 2022 were retrospectively studied. Patients who developed PPS and patients who did not develop PPS were included as two different groups in the study. We investigated whether there was a significant difference between the two groups in terms of SII. Results: A total of 228 patients were enrolled in the study, 132 in the patient group and 96 in the control group. The mean age was 63.48 years in the patient group and 65.09 years in the control group and no statistically significant difference was found (p 0.34). There were also no significant differences between the two groups in terms of gender (p 0.47), hypertension (p 0.22), hyperlipidemia (p 0.66), coronary artery disease (p 0.76), diabetes (p 0.023), smoking (p 0.35), and chronic obstructive pulmonary disease (p 0.49). The median value for SII was 568.91 (530.17) in the patient group and 634.79 (613.23) in the control group, and no significant difference was found between the groups (p 0.208). Statistically significant differences were found in hemoglobin (p 0.03), hematocrit (p 0.02), and glucose (p 0.018) values between both groups. Conclusion: The SII is not a useful parameter for predicting post-pericardiotomy syndrome. Comprehensive studies with larger patient populations including subgroup analyzes are needed in this regard.
13 September 2025 in Bratislava Medical Journal